PT Indofarma Tbk (ISX:INAF) OCF Margin %: -171.94% (As of Dec. 2025)

What is PT Indofarma Tbk OCF Margin %?

PT Indofarma Tbk ISX:INAF 8 OCF Margin % is -171.94% as of Dec. 2025. GuruFocus rates ISX:INAF with a GF Score™ of 8/100 and a GF Value™ of Rp176.99. The stock has 6 warning signs investors should review.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. PT Indofarma Tbk's Cash Flow from Operations for the three months ended in Dec. 2025 was Rp-30,632 Mil. PT Indofarma Tbk's Revenue for the three months ended in Dec. 2025 was Rp17,815 Mil. Therefore, PT Indofarma Tbk's OCF Margin % for the quarter that ended in Dec. 2025 was -171.94%.

As of today, PT Indofarma Tbk's current OCF Yield % is -53.77%.

The historical rank and industry rank for PT Indofarma Tbk's OCF Margin % or its related term are showing as below:

ISX:INAF' s OCF Margin % Range Over the Past 10 Years
Min: -138.56 Med: -6.09 Max: 9.02
Current: -138.56

During the past 13 years, the highest OCF Margin % of PT Indofarma Tbk was 9.02%. The lowest was -138.56%. And the median was -6.09%.

ISX:INAF's OCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 9.94 vs ISX:INAF: -138.56

PT Indofarma Tbk OCF Margin % Related Terms

PT Indofarma Tbk OCF Margin % Historical Data

* Premium members only.

The historical data trend for PT Indofarma Tbk's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Indofarma Tbk OCF Margin % Chart

PT Indofarma Tbk Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

3.20

-7.75

-37.08

-10.29

-138.56

PT Indofarma Tbk Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
OCF Margin %	Get a 7-Day Free Trial															46.90	-50.97	5.13	-243.10	-171.94

ISX:INAF vs ZTS, VTRS, NBIX: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PT Indofarma Tbk's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Indofarma Tbk OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Indofarma Tbk's OCF Margin % distribution charts can be found below:

* The bar in red indicates where PT Indofarma Tbk's OCF Margin % falls into.

Save Embed

8GF Score

PT Indofarma Tbk ISX:INAF

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

PT Indofarma Tbk OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

PT Indofarma Tbk's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-209981.609	/	151550.542
	=	-138.56 %

PT Indofarma Tbk's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-30631.814	/	17815.307
	=	-171.94 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -171.94% mean?

PT Indofarma Tbk (ISX:INAF) has a OCF Margin % of -171.94% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PT Indofarma Tbk and its competitors.

Is PT Indofarma Tbk's OCF Margin % too high?

PT Indofarma Tbk's current OCF Margin % is -171.94%. Overall, PT Indofarma Tbk has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.

How does PT Indofarma Tbk's OCF Margin % compare to ZTS and VTRS?

PT Indofarma Tbk's OCF Margin % of -171.94% can be compared against companies in the Drug Manufacturers industry. The industry median OCF Margin % is 9.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Drug Manufacturers company?

The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PT Indofarma Tbk and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Indofarma Tbk's current OCF Margin % is -171.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is PT Indofarma Tbk stock overvalued right now?

PT Indofarma Tbk (ISX:INAF) has a current OCF Margin % of -171.94%. The stock's GF Value™ is Rp176.99, compared to a current price of Rp126.00 — trading 28.8% below its estimated fair value. The current OCF Margin % is -171.94%. PT Indofarma Tbk's overall GF Score™ is 8/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For PT Indofarma Tbk (ISX:INAF), the current OCF Margin % is -171.94% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Indofarma Tbk (ISX:INAF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Indofarma Tbk stock appears to be undervalued. The current stock price of Rp126.00 is trading 28.8% below its estimated GF Value™ of Rp176.99.

Key valuation signals for ISX:INAF:

OCF Margin %: -171.94%
GF Value™: Rp176.99 vs. price of Rp126.00 (28.8% below fair value)
GF Score™: 8/100 with 6 warning signs

No single metric tells the full story. See the ISX:INAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Indofarma Tbk Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies ISX:MERK ISX:DVLA ISX:PEHA ISX:PYFA ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085

Address Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530

Website https://www.indofarma.id

PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others. The Medicine business segment includes drug production, marketing distribution, and sales. The Medical Device Segment includes medical devices and other products. Company generates majority revenue from the Medicine segment. The Company classifies its distribution segments based on geographic regions into six areas, namely Java, Sumatra, Kalimantan, Sulawesi, Bali dan West Nusa Tenggara (NTB),as well as the Eastern Indonesia region.

8GF Score

Get the complete analysis for ISX:INAF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp126.00

Price

Rp176.99

GF Value

View ISX:INAF Analysis

See OCF Margin % data for all stocks →